Management of a patient with stage IIIA (N2) NSCLC.
The appropriate treatment of patients with stage IIIA (N2) nonsmall-cell lung cancer (NSCLC) is unclear. With this case report and review, we address the history, assessment, and management of a 67-year-old patient with this diagnosis, and then discuss the challenges in managing N2 disease, as well as the roles of systemic therapy, surgery, and postoperative radiation therapy.
Carlson
Kathryn
K
Department of Hematology and Medical Oncology, Emory University, School of Medicine, Emory Winship Cancer Institute, Atlanta, Georgia 30322, USA.
Fowler
B Zach
BZ
Miller
Daniel L
DL
Gal
Anthony
A
Ramalingam
Suresh
S
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy*; D008197:Lymph Node Excision; D008297:Male; D020360:Neoadjuvant Therapy; D011013:Pneumonectomy; D018714:Radiotherapy, Adjuvant; D020775:Thoracic Surgery, Video-Assisted